UCSF 41st Annual Advances in Heart Disease 2024
December 6–8, 2024 | San Francisco & Virtual
The UCSF 41st Annual Advances in Heart Disease is a premier three-day continuing medical education (CME) course designed for healthcare professionals seeking the latest updates in cardiovascular medicine. Now in its 41st year, this comprehensive program delivers cutting-edge, evidence-based insights to enhance clinical practice and improve patient care.
Key Features
-
Hybrid Format: Attend in person or join live online from anywhere.
-
30-Day Replay Access: All sessions are recorded and available for on-demand viewing.
-
Expert Faculty: Led by distinguished UCSF cardiologists and national leaders in cardiovascular care.
Course Topics
-
New guidelines and therapies for:
-
Coronary artery disease
-
Heart failure and arrhythmias
-
Lipid and blood pressure management
-
Pulmonary hypertension
-
Diabetes and cardiovascular risk
-
-
Contemporary issues:
-
GLP-1 agonists and cardiovascular outcomes
-
Mechanical circulatory support
-
Stroke prevention in atrial fibrillation
-
Cardio-renal syndromes
-
Erectile dysfunction and vascular health
-
Diversity in sex- and race-based outcomes
-
Learning Objectives
Participants will be able to:
-
Apply the latest clinical trial evidence to the management of cardiovascular disease
-
Implement best practices for device therapy, ablation, and structural interventions
-
Integrate risk stratification tools and preventive strategies into daily practice
-
Navigate complex cases involving comorbidities such as diabetes, renal disease, or COVID-19 sequelae
-
Improve diagnostic accuracy in evaluating chest pain, palpitations, and shortness of breath
Target Audience
-
Cardiologists
-
Internists
-
Family physicians
-
Hospitalists
-
Nurse practitioners and physician assistants
-
Fellows-in-training
Accreditation
-
Offers up to 18.75 AMA PRA Category 1 Credits™
-
Suitable for maintenance of certification and licensure requirements
Reviews
There are no reviews yet.